+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay



Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay



Infection 38(6): 453-458



Many studies have evaluated the clinical characteristics of Gram-negative bacteria (GNB) pneumonia. However, in most cases the bacteriological diagnosis is based on unreliable respiratory samples, and research rarely focuses on only bacteraemic patients. The aim of this study was to describe the incidence, clinical characteristics, outcomes, and factors associated with severity during the hospital stay of patients diagnosed with bacteraemic community-acquired pneumonia (CAP) due to GNB. Patients consecutively admitted with bacteraemic CAP due to GNB were enrolled in the study, with exclusion of additional foci of infection. CAP due to GNB accounted for 1.2% of the total CAP cases admitted and 3.5% of those with a confirmed aetiological diagnosis. Fifty-one patients were studied (mean age: 73 ± 11.3 years). Escherichia coli (30 cases; 58.8%) and Klebsiella pneumoniae (9 cases; 17.6%) were the most commonly isolated strains. The main symptoms were fever, cough, and dyspnoea. Eleven (21.6%) patients presented mental confusion, ten (19.6%) followed a severe clinical course, and six (11.8%) died. Absence of fever, radiologically multilobar involvement, and the prescription of an inadequate empirical antimicrobial therapy were independent factors associated with severity during the hospital stay. Bacteraemic CAP due to GNB is an uncommon entity. Among the patients studied, E. coli was the main GNB found. A total of 19.6% of patients followed a severe clinical course. The factors identified in this study may alert physicians to a group of patients at risk of suffering complications during their hospital stay.

(PDF emailed within 0-6 h: $19.90)

Accession: 051747630

Download citation: RISBibTeXText

PMID: 20878457

DOI: 10.1007/s15010-010-0058-4


Related references

Community-acquired pneumonia and Gram-negative bacilli in Cambodia-incidence, risk factors and clinical characteristics. Transactions of the Royal Society of Tropical Medicine and Hygiene 112(2): 57-63, 2018

Hospital admission, duration of stay and mortality in community-acquired pneumonia in an acute care hospital. Correlation between a pneumonia prognosis index and conventional clinical criteria for assessing severity. Enfermedades Infecciosas Y Microbiologia Clinica 22(2): 64-69, 2004

Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. Archives of Internal Medicine 162(16): 1849-1858, 2002

Factors influencing mortality in hospital-acquired pneumonia caused by Gram-negative bacteria in China. Journal of Infection and Public Health 2019, 2019

Clinical outcomes and risk factors of community-acquired pneumonia caused by gram-negative bacilli. European Journal of Clinical Microbiology and Infectious Diseases 27(8): 657-661, 2008

Utility of fine severity score for pneumonia in predicting the duration of hospital stay in patients with community acquired pneumonia. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 426, 2003

Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea. Diagnostic Microbiology and Infectious Disease 78(4): 457-461, 2014

PIC6 Using a Pneumonia-Specific Severity of Illness Model in Assessing Variation in Hospital Length of Stay for Community-Acquired Pneumonia Patients. Value in Health 1(1): 69-69, 1998

Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality. Clinical Infectious Diseases 61 Suppl 2: S87-S93, 2016

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia. Critical Care 23(1): 79, 2019

Resistance of gram negative bacteria in hospital acquired pneumonia: a prospective study. Brazilian Journal of Infectious Diseases 20(1): 113-114, 2016

Factors associated with prolonged hospital stay in community-acquired pneumonia. Enfermedades Infecciosas Y Microbiologia Clinica 27(3): 160-164, 2009

Factors influencing length of hospital stay in community-acquired pneumonia: a study in 27 community hospitals. Epidemiology and Infection 132(5): 821-829, 2004

Novel pharmacotherapy for the treatment of hospital-acquired and ventilator-associated pneumonia caused by resistant gram-negative bacteria. Expert Opinion on PharmacoTherapy 19(4): 397-408, 2018

Factors associated with length of stay in hospital for suspected community-acquired pneumonia. Canadian Respiratory Journal 13(6): 317-324, 2006